Treosulfan Exposure Predicts Thalassemia-Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation

A toxicity-reduced conditioning regimen with treosulfan, fludarabine, and thiotepa in patients with high-risk β-thalassemia major has significantly improved hematopoietic stem cell transplantation (HCT) outcomes. However, complications resulting from regimen-related toxicities (RRTs), mixed chimeris...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Pharmacol Ther
Main Authors: Pai, Aswin Anand, Mohanan, Ezhilpavai, Panetta, John C., Kulkarni, Uday P., Illangeswaran, Raveen Stephen Stallon, Balakrishnan, Balaji, Jayaraman, Agila, Edison, Eunice S., Lakshmi, Kavitha M., Devasia, Anup J., Fouzia, Nambiathayil Aboobacker, Korula, Anu, Abraham, Aby, George, Biju, Srivastava, Alok, Mathews, Vikram, Standing, Joseph F., Balasubramanian, Poonkuzhali
Formato: Artigo
Idioma:Inglês
Publicado em: 2024
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7615782/
https://ncbi.nlm.nih.gov/pubmed/37846495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.3078
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados